Kavar Capital Partners Group’s Insmed INSM Stock Holding History

Kavar Capital Partners Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-15	Closed	–	–	228
2015 Q4	$0	Hold	15	–	–	﹤0.01%	503
2015 Q3	$0	Buy	+15	New	+$374	﹤0.01%	506

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kavar Capital Partners Group's INSM Position: Q1 2016 in Review

Kavar Capital Partners Group sold out of Insmed (INSM) in Q1 2016, closing a stake of 15 shares.

Kavar Capital Partners Group first reported a position in INSM in Q3 2015 and held it in 2 quarters. The position peaked at $0 in Q4 2015. 101 funds tracked by Wall St. Rank hold INSM as of Q1 2016.

Kavar Capital Partners Group reported no remaining Insmed position as of Q1 2016 after selling out during the quarter.
Kavar Capital Partners Group sold 15 Insmed shares in Q1 2016.
Kavar Capital Partners Group first reported a position in Insmed in Q3 2015 and held it in 2 quarters.
Kavar Capital Partners Group's Insmed position peaked at $0 in Q4 2015.
101 funds tracked by Wall St. Rank held Insmed as of Q1 2016.

Based on Kavar Capital Partners Group's 13F filing for Q1 2016, filed 13 May 2019.